Predictive factors for early mortality after initiation of regorafenib or trifluridine/tipiracil in refractory metastatic colorectal cancer. This is an ASCO Meeting Abstract from the 2019 ASCO Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results